jRCT2071250135招募中不适用
A Long-term study (Phase III) of NS-304 in patients with intermittent claudication (IC) resulting from arteriosclerosis obliterans (ASO) (NS304A-P3-2)
未提供0 个研究点目标入组 50 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
入排标准
- 年龄范围
- 40age old over 至 No limit（—）
- 性别
- All
入选标准
- •Patients with intermittent claudication (IC) resulting from arteriosclerosis obliterans (ASO)
- •Patients whose ABI is not more than 0.90 at rest.
- •Patients whose PWT measured in the treadmill exercise test meets selection criteria.
排除标准
- •Patients who have severe ischemia of lower extremities of Stage III or over in Fontaine classification or potentially has severe ischemia of lower extremities
研究者
相似试验
尚未招募
3 期
AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightDiabetes Mellitus, Type 2ObesityNCT07400107Novo Nordisk A/S1,000
招募中
3 期
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose WeightNCT07339423Novo Nordisk A/S1,150
招募中
1 期
A study to see the effect of NNC0194-0499 alone or in combination with semaglutide on blood sugar control in people living with type 1 diabetes.2024-519533-38-00Novo Nordisk A/S96
招募中
2 期
A research study comparing how well different doses of the medicine NNC0519-0130 can reduce kidney damage in people living with chronic kidney disease.2024-510846-15-00Novo Nordisk A/S120
招募中
2 期
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 DiabetesDiabetes Mellitus, Type 2NCT07415954Novo Nordisk A/S270